AZmed

AZmed is a healthcare technology company specializing in artificial intelligence (AI) solutions for medical diagnostics. The company's flagship product, Rayvolve, is an AI diagnostic tool designed to detect fractures on standard X-rays. This tool has received clearance from the U.S. Food and Drug Administration (FDA), underscoring its reliability and effectiveness. Rayvolve aims to assist doctors by saving time and increasing the accuracy of diagnoses, particularly in emergency room settings where quick and precise assessments are crucial.

AZmed primarily serves hospitals, emergency departments, and radiology units, providing them with advanced diagnostic capabilities. The company operates in the healthcare technology market, focusing on AI-driven innovations to improve patient care. Its business model revolves around selling and licensing its software to medical institutions, generating revenue through subscription fees and service contracts.

By integrating Rayvolve into existing medical imaging systems, AZmed ensures that its solution is easily accessible to radiologists and emergency physicians. The software's predictions are available within minutes and can be reviewed alongside the original X-ray images, helping to ensure that no fractures go unnoticed, regardless of the time or urgency of the situation.

Keywords: AI diagnostics, fracture detection, X-rays, FDA clearance, emergency rooms, radiology, healthcare technology, medical imaging, patient care, deep learning.